The first total synthesis of the natural cytotoxic agent sporiolide A has been accomplished from D-glucal in 16 steps with 6.1% overall yield. Carbohydrates were applied as the chiral templates to manipulate the absolute configuration during the synthesis. Pyridinium chlorochromate (PCC)-promoted transformation of the cyclic enol-ether to lactone, followed by Yamaguchi esterification and intramolecular ring closure metathesis, greatly facilitates synthesis of the target compound.
Introduction
Marine fungi are attracting increasing attention as a potential source of new pharmaceuticals and pharmaceutical leads. 1 These leading compounds include fungal metabolites containing 12-membered lactone rings such as sporiolides [A (1), B (2)] and pandangolide 1 (3) isolated from the cultured broth of Cladosporium sp. from an Okinawan marine brown alga Actinotrichia fragilis and the Red Sea sponge Niphates rowi ( Figure  1 ). 2 Sporiolides A and B exhibit cytotoxicity against L1210 cells with IC 50 values of 0.13 and 0.81 µg/mL, respectively. Importantly, sporiolide A shows antifungal activity against Candida albicans (MIC 16.7 µg/mL), Cryptococcus neoformans (8.4 µg/mL), Aspergillus niger (16.7 µg/mL), and Neurospora crassa (8.4 µg/mL), together with antibacterial activity against Micrococcus luteus (16.7 µg/mL). In 2004, Kobayashi and coworkers proposed a chemical structure of sporiolide A corresponding to 3-O-benzoyl pandangolide 1 based on spectroscopic data, 3 although the absolute configuration of pandangolide 1 was not determined until 2005. 4 The potential biological importance, as well as the uncertainty of its absolute structural configuration, marked sporiolide A as a synthetic target for us. Herein, we report our efforts leading to the first total synthesis of sporiolide A (1) using chiral carbohydrate templates.
C-3 and C-5 in sporiolide A (path A, Scheme 1). Alternatively, as our subsequent investigation would make clear, acid 6b could be obtained from the appropriately functionalized lactone 9, which could be prepared from commercially available D-glucal (path B, Scheme 1).
Initially, we tried to prepare key intermediate 8 starting from D-xylose as illustrated in Scheme 2. Thus, benzylation of known D-xylofuranosyl derivative 10 5 and subsequent deallylation (tBuOK in DMSO and Hg(OAc) 2 in THF/H 2 O) 6 gave hemiacetal 12 in good yield (80% from 10). Standard Wittig reaction of 12 with methyltriphenylphosphonium bromide in anhydrous THF at -50°C generated olefin 13, in which the hydroxyl group was benzoylated using BzCl and pyridine (f14). Acid hydrolysis of 14 with TsOH hydrate (f15) and regioselective iodination 7 with Ph 3 P and I 2 furnished iodide 16 in an isolated yield of 57% over 4 steps. Attempted S N 2 substitution of iodide to the cyano group with KCN using many known procedures was fruitless. 8 However, in a model study, this transformation was successfully carried out when methyl ether was used in place of the benzoate group. Furthermore, if the benzoate group was replaced by 4-methoxybenzyl ether, the desired compound failed to form under the same reaction conditions. Since the literature 9 suggested that this problem might be hard to overcome, we focused our attention on path B of Scheme 1, as shown in Scheme 3.
D-Glucal was regioselectively silylated at the 3-and 6-positions according to a literature method 10 to give compound 17, which was then treated with PMBCl and NaH in DMF, affording fully protected glucal 18 (75% yield from D-glucal). Regioselective desilylation of 18 with HF-pyridine complex 11 gave 19, providing a free primary hydroxyl, which was then oxidized by Swern oxidation and alkenated under Witttig reaction conditions (f20). This D-glucal derivative 20 was subjected to pyridinium chlorochromate (PCC)-promoted transformation of cyclic enol ether to lactone 12 at 45°C in the presence of silica gel to give key intermediate 9 in 74% yield. Treatment of 9 with NaOMe in MeOH was formed methyl ester 21, in which free OH was blocked by a benzyl group using benzyltrichloroacetimdate 13 and trimethylsilyltrifluoromethanesulfonate (TMSOTf), affording compound 22. Hydrolysis of 22 with LiOH, followed by esterification with (S)-6-hepten-2-ol (7) ate 5 in 58% yield over four steps. Diene 5 was then exposed to the Grubbs catalyst [PHCHdRuCl(PCy 3 ) 2 , 30 mol/%, 1.4 × 10 -4 M in CH 2 Cl 2 ] 18 to undergo an intramolecular ring closure metathesis (RCM) to produce macrolide 4 in a form of E,Z mixture (E/Z ) 2/1). Final hydrogenation of 4 with H 2 in the presence of Pd/C reduced both benzyl and double bond to accomplish the total synthesis of sporiolide A, identical in all physical data to that reported for the natural product. 3 In summary, we have finished the first total synthesis of sporiolide A in 16 steps and 6.1% overall yield. The required stereochemical configurations at C-3 and C-5 in sporiolide A were successfully secured by using D-glucal as the chiral template. PCC-promoted transformation of the cyclic enol ether to lactone, Yamaguchi esterification, and Grubbs ring closure metathesis greatly facilitated the synthesis of our target. As exemplified in this study, carbohydrate moieties provide versatile synthons in asymmetric synthesis of natural products. 19 This report provides an attractive method for the preparation of other natural macrolides, such as pandangolide 1a, pandangolides 1 and 2, and sporiolide B. 1d,20 The screening of cytotoxic activities toward other cell lines are currently under investigation and will be reported in due course.
Experimental Section 3,6-O-Di-tert-butyldimethylsilyl-4-O-p-methoxybenzyl-D-glucal (18).
To a stirred solution of 17 (5.5 g, 14.7 mmol) in anhydrous DMF (30 mL) was added NaH (720 mg, 30 mmol) portionwise at 0°C. After 30 min, p-methoxybenzyl chloride (2.4 mL, 18 mmol) was added dropwise under the same reaction conditions. The mixture was kept stirring at room temperature for 2 h, poured into ice-water (30 mL), and extracted with EtOAc (2 × 100 mL). The combined organic layer was dried over anhydrous Na 2 SO 4 and concentrated to dryness. Purification of the residue on column chromatography (petroleum ether-EtOAc, 25:1) afforded 18 (6.0 g, 83%) as a colorless syrup: [R] to rt, 2 h; (ii) BuLi, Ph3PCH3Br, THF, -50°C to rt, 3 h, 75% over two steps; (e) PCC, silica gel, CH2Cl2, 45°C, 6 h, 74%; (f) NaOMe, MeOH, 3 h, 83%; (g) BnOC(NH)CCl3, TMSOTf, CH2Cl2, 3 h, 75%; (h) (i) LiOH, THF/MeOH/H2O, 12 h; (ii) (S)-6-hepten-2-ol, 2,4,6-trichlorobenzoyl chloride, TEA, DMAP, THF, 18 h, 79% in two steps; (i) TBAF, THF, 4 h, 83%; (j) BzCl, Pyr, DMAP, 4 h, 95%; (k) DDQ, CH2Cl2/ H2O, 2 h, 90%; (l) Dess-Martin periodinane, CH2Cl2, 3 h, 82%; (m) 30% PhCHdRuCl2(PCy3)2, CH2Cl2, reflux, 24 h, 72% (E/Z ) 2/1); (n) H2, Pd/C, MeOH, 24 h, 91%. -5.2, -4.6, -4.4, 18.0, 18.4, 25.8, 25.9, 55.2, 61.9, 69.0, 73.5, 76.2, 78.0, 103.2, 113.8, 129.5, 130.6, 143. 
NMR (CDCl
3 ) δ -5.4,
3-O-tert-Butyldimethylsilyl-4-O-p-methoxybenzyl-D-glucal (19).
To a solution of 18 (5.8 g, 11.7 mmol) in THF (120 mL) was added HF/Pyr (70%, 7 mL) dropwise at 0°C. The reaction mixture was warmed to room temperature, stirred for 2 h, diluted with EtOAc (100 mL), and neutralized with saturated aqueous NaHCO 3 . The aqueous phase was further extracted with EtOAc (100 mL). After being washed with brine and dried over anhydrous Na 2 SO 4 , the organic layer was concentrated in vacuo. The residue was purified by column chromatography (petroleum ether-EtOAc, 4:1) to give 19 (3.5 g, 78%) as a colorless syrup: [R] -4.4, 17.9, 25.8, 55.2, 61.9, 68.6, 73.5, 76.4, 77.0, 103.7, 113.7, 129.6, 131.2, 143.4, 159.4 
2R,3R,4R)-4-(tert-Butyldimethylsilyloxy)-3-(p-methoxybenzyloxy)-2-vinyl-2,3-dihydro-2H-pyran (20).
To a stirred solution of oxalyl chloride (1.1 mL, 13 mol) in dry CH 2 Cl 2 (20 mL) at -78°C was added DMSO (2.1 mL, 28 mmol) dropwise under N 2 atmosphere. The reaction mixture was stirred under these conditions for 30 min, and a solution of alcohol 19 (3.4 g, 8.9 mmol) in dry CH 2 Cl 2 (30 mL) was then added slowly. After 1 h of stirring at -78°C, Et 3 N (8.3 mL, 60 mol) was added, and the reaction was stirred for another 30 min at ambient temperature, quenched with saturated aqueous NH 4 Cl (30 mL), and extracted with CH 2 Cl 2 (30 mL). The combined organic phase was washed with water (30 mL) and brine (30 mL), dried over anhydrous Na 2 SO 4 , and concentrated under reduced pressure to furnish the aldehyde, which was directly used in the next step without further purification. In a parallel reaction flask, a 2.5 M solution of n-BuLi in hexane (5.6 mL, 14 mmol) was added under N 2 atmosphere to a stirred suspension of methyltriphenylphosphonium bromide (4.2 g, 11.6 mmol) in dry THF (40 mL) at -50°C. The mixture was allowed to warm to room temperature, stirred for 1 h, and cooled to -50°C again. To this mixture a solution of above crude aldehyde in dry THF (30 mL) was added dropwise, and the resulting mixture was stirred at room temperature for 2 h, quenched with aqueous NH 4 Cl, and extracted with EtOAc (2 × 100 mL). The combined organic extracts were dried over anhydrous Na 2 SO 4 and concentrated in vacuo. The residue was purified by column chromatography (petroleum etherEtOAc, 10:1) to give 20 (2.5 g, 75% yield over two steps) as a colorless syrup: [R] -4.5, 18.0, 25.8, 55.2, 69.1, 73.8, 78.1, 80.1, 103.9, 113.7, 118.0, 129.6, 130.2, 134.6 (4R,5R,6R)-4-(tert-Butyldimethylsilyloxy)-5-(p-methoxybenzyloxy)-6-vinyltetrahydropyran-2-one (9). To a solution of compound 20 (840 mg, 2.2 mmol) in CH 2 Cl 2 (100 mL) was added the mixture of PCC (1.5 g, 6.6 mmol) and silica gel (1.8 g). The stirred suspension was refluxed for 6 h and then cooled and filtered through Celite. The Celite pad was washed several times with EtOAc, and the combined filtrates were concentrated. The crude product was purified by column chromatography (petroleum etherEtOAc, 6:1) to give 9 (650 mg, 74%) as a colorless syrup: [R] Hz), 3.46 (t, 1H, J ) 4.8 Hz), 3.81 (s, 3H), 4.17 (dd, 1H, J ) 4.3, 8.6 Hz), 4.56 (d, 1H, J ) 11.1 Hz), 4.62 (d, 1H, J ) 17.8, 25.6, 36.9, 55.3, 68.8, 72.7, 79.8, 81.0, 113.9, 117.8, 129.3, 129.5, 134.4, 159.5, 169.1. Anal. Calcd for C 21 H 32 O 5 Si: C, 64.25; H, 8.22. Found: C, 63.95; H, 8.18 .
Methyl (3R,4R,5S)-3-(tert-Butyldimethylsilyloxy)-5-hydroxy-4-(p-methoxybenzyloxy)hept-6-enoate (21). To a solution of compound 9 (629 mg, 1.6 mmol) in anhydrous MeOH (15 mL) was added 1 N NaOMe in MeOH until pH 9-10. The reaction mixture was stirred at room temperature for 3 h under these conditions, neutralized with Amberlite IR-120 (H + ), and filtered. The filtrate was concentrated to dryness under diminished pressure and purified by silica gel column chromatography 5:1) -4.8, 17.9, 25.6, 37.0, 51.6, 55.3, 68.8, 72.7, 79.8, 81.0, 113.8, 117.9, 129.5, 129.7, 134.4, 159.6, 172. 17.9, 25.7, 38.3, 51.4, 55.2, 69.7, 69.7, 72.9, 80.2, 82.2, 113.6, 119.8, 127.3, 127.5, 128.2, 129.4, 130.8, 135.6, 138.7, 159.1, 172.6. Anal. Calcd for C 29 H 42 O 6 Si: C, 67.67; H, 8.22. Found: C, 67.91; H, 8.13 .
(S)-Hept-6-en-2-yl (3R,4R,5S)-5-Benzyloxy-3-(tert-butyldimethylsilyloxy)-4-(p-methoxybenzyloxy)hept-6-enoate (23). The methyl ester 22 (437 mg, 0.85 mmol) was dissolved in THF/MeOH/ H 2 O (15 mL, 2:1:1) and cooled with ice-water bath. LiOH‚H 2 O (105 mg, 2.5 mmol) was added and the resulting mixture was stirred at room temperature for 12 h, neutralized with 1 N HCl, and then extracted with EtOAc. The combined organic phase was dried over anhydrous Na 2 SO 4 and concentrated to afford acid intermediate. Without further purification, the crude acid was dissolved in anhydrous THF (15 mL) and treated with triethylamine (0.12 mL, 0.9 mmol) and 2,4,6-trichlorobenzoyl chloride (0.13 mL, 0.85 mmol), successively. After being stirred at room temperature for 1 h, a solution of (S)-6-hepten-2-ol (113 mg, 1.0 mmol) and DMAP (110 mg, 0.9 mmol) in THF (5 mL) were added. The reaction mixture was stirred at room temperature for another 18 h and was then quenched by aqueous NH 4 Cl. The water phase was separated and extracted with EtOAc (2 × 25 mL). The combined organic extracts were dried and evaporated. Purification of the residue by silica gel column chromatography (petroleum ether-EtOAc, 7:1) gave 23 (400 mg, 79% over two steps) as a colorless syrup: [R] 
